We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
+22.33%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$385B
AUM Growth
+$32.1B
Cap. Flow
-$35.1B
Cap. Flow %
-9.14%
Top 10 Hldgs %
30.5%
Holding
11,975
New
1,989
Increased
4,461
Reduced
4,218
Closed
1,130

Sector Composition

Rank Sector Weight
1 Technology 3.78%
2 Healthcare 3.27%
3 Industrials 2.02%
4 Financials 2.02%
5 Consumer Discretionary 1.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SDOT icon
10101
Sadot Group
SDOT
$12.3M
$98K ﹤0.01%
+28
New +$105K
PEI
10102
PUT
DELISTED
Pennsylvania Real Estate Investment Trust
PEI
$98K ﹤0.01%
6,533
+4,046
+163% +$45.7K
CNVS icon
10103
Cineverse
CNVS
$63.9M
$97K ﹤0.01%
+7,557
New +$91.9K
EMX
10104
DELISTED
EMX Royalty
EMX
$97K ﹤0.01%
28,992
+16,496
+132% +$47.8K
MDXG icon
10105
CALL
MiMedx Group
MDXG
$622M
$97K ﹤0.01%
+10,700
New +$77K
MIN
10106
Aberdeen Intermediate Income Fund
MIN
$282M
$97K ﹤0.01%
25,477
-10,000
-28% -$37.7K
SNCR
10107
CALL
DELISTED
Synchronoss Technologies
SNCR
$97K ﹤0.01%
+2,289
New +$66.2K
TLPH icon
10108
Talphera
TLPH
$63.8M
$97K ﹤0.01%
3,895
+2,982
+327% +$91.1K
KRBP
10109
DELISTED
Kiromic BioPharma, Inc. Common Stock
KRBP
$97K ﹤0.01%
+388
New +$110K
NPTN
10110
CALL
DELISTED
NEOPHOTONICS CORP
NPTN
$97K ﹤0.01%
+10,700
New +$82.8K
ALDX icon
10111
PUT
Aldeyra Therapeutics
ALDX
$94.1M
$96K ﹤0.01%
+14,000
New +$98.3K
MFIN icon
10112
CALL
Medallion Financial
MFIN
$264M
$96K ﹤0.01%
+19,600
New +$77.4K
MIST icon
10113
CALL
Milestone Pharmaceuticals
MIST
$137M
$96K ﹤0.01%
+14,300
New +$95.7K
TUSK icon
10114
Mammoth Energy Services
TUSK
$160M
$96K ﹤0.01%
+21,408
New +$52.1K
ONCT
10115
PUT
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
$96K ﹤0.01%
+980
New +$62K
BWEN icon
10116
Broadwind
BWEN
$127M
$95K ﹤0.01%
12,041
-61,616
-84% -$267K
SLNO
10117
CALL
DELISTED
Soleno Therapeutics
SLNO
$95K ﹤0.01%
3,293
+1,786
+119% +$51.5K
ENZ
10118
PUT
DELISTED
Enzo Biochem, Inc.
ENZ
$95K ﹤0.01%
37,700
+23,600
+167% +$51.4K
ARAV
10119
DELISTED
Aravive, Inc. Common Stock
ARAV
$95K ﹤0.01%
+16,911
New +$92.8K
BLCM
10120
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
$95K ﹤0.01%
+26,970
New +$114K
AUD
10121
PUT
DELISTED
Audacy, Inc.
AUD
$95K ﹤0.01%
38,500
-13,200
-26% -$27K
GLOG
10122
CALL
DELISTED
GASLOG LTD
GLOG
$95K ﹤0.01%
+25,500
New +$77.1K
GMLP
10123
PUT
DELISTED
Golar LNG Partners LP
GMLP
$95K ﹤0.01%
36,900
+15,800
+75% +$37.6K
SLAI
10124
DELISTED
SOLAI Ltd ADS
SLAI
$94K ﹤0.01%
+150
New +$33.4K
GLAD icon
10125
Gladstone Capital
GLAD
$446M
$94K ﹤0.01%
5,328
-2,172
-29% -$35.2K

Similar funds

Ken Griffin's Q4 2020 Portfolio in Review

As of Q4 2020, Ken Griffin held 11,975 positions worth $385B, up 9.1% from $353B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Ken Griffin withdrew a net $35.1B in Q4 2020, closing 1,130 positions and reducing 4,218 holdings. Its most notable exit was Immunomedics Inc, an estimated $213M position sold in full.

By sector, the portfolio is most concentrated in Technology at 3.8% of assets, up from 3% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Ken Griffin opened a new position in S&P Global worth $114M.

  • Ken Griffin's largest Q4 2020 buy was S&P Global: 345,785 shares worth $114M.
  • Ken Griffin added most to iShares Core S&P 500 ETF in Q4 2020, an estimated $1.16B increase.
  • Ken Griffin's biggest Q4 2020 reduction was Amazon, cutting an estimated $1.55B.
  • Ken Griffin fully exited Immunomedics Inc in Q4 2020, selling an estimated $213M.
  • Ken Griffin's ten largest holdings make up 31% of its $385B portfolio in Q4 2020.
  • Ken Griffin opened 1,989 new positions and closed 1,130 in Q4 2020.
  • Ken Griffin's portfolio value rose 9.1% quarter-over-quarter to $385B.

Based on Citadel Advisors's 13F filing for Q4 2020, filed 16 Feb 2021.